Funder: European Commission

Due Dates: October 9, 2025 (Stage 1) | April 29, 2026 (Stage 2)

Funding Amounts: €20,202,000 total; one grant expected; project duration typically 4–5 years

Summary: Funds the development of a federated data platform to link transdiagnostic brain dysfunction symptoms with biological markers, advancing precision medicine across CNS disorders.

Key Information: Legal entities in the UK and Canada are eligible for funding.